GlassScriptPhysician profile
Audra Mcquade
NPI 1316694961
$3,281.53
in general payments reported to CMS, 2019-2025
32 companies · $422 in 2025
The $422 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $581 · 2023: $1,700 · 2024: $579 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,106 · Travel and Lodging: $550 · Education: $45.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,105.83 |
| Travel and Lodging | $549.69 |
| Education | $45.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $925.60 | 2023 | Vns Therapy |
| Abbvie INC. | $514.21 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $190.24 | 2023-2025 | |
| Harmony Biosciences LLC | $184.69 | 2023-2025 | Wakix |
| Ucb, INC. | $168.90 | 2022-2025 | Cimzia, Bimzelx, Fintepla |
| Avadel Cns Pharmaceuticals, LLC | $140.08 | 2024-2025 | Lumryz |
| Lundbeck LLC | $126.16 | 2022-2025 | Vyepti, Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $115.71 | 2022 | |
| Lilly USA, LLC | $108.60 | 2022-2025 | Emgality, Reyvow, Zepbound |
| Eisai INC. | $78.01 | 2022-2024 | |
| Axsome Therapeutics, INC. | $75.02 | 2025 | Symbravo, Sunosi |
| Upsher-Smith Laboratories LLC | $74.52 | 2022-2023 | |
| Argenx US, INC. | $60.86 | 2023 | Vyvgart |
| Takeda Pharmaceuticals U.S.A., INC. | $57.36 | 2023-2024 | Gammagard, Hyqvia |
| Corium, LLC | $50.96 | 2022-2023 | Adlarity |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $48.91 | 2024-2025 | Inspire |
| Tg Therapeutics, INC. | $45.39 | 2023 | |
| Janssen Pharmaceuticals, INC | $29.61 | 2022 | |
| Pfizer INC. | $29.53 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $28.35 | 2023 | Rexulti |
| Cala Health, INC. | $25.65 | 2023 | Cala Trio, Cala Kiq |
| Kyowa Kirin, INC. | $25.26 | 2023 | Nourianz |
| Fisher & Paykel Healthcare INC | $22.53 | 2025 | Fisher & Paykel Healthcare |
| Banner Life Sciences, LLC | $19.39 | 2022 | |
| Sunovion Pharmaceuticals INC. | $19.31 | 2022 | |
| Tanabe Pharma America, INC. | $18.15 | 2024 | |
| Biogen, INC. | $17.59 | 2023 | Skyclarys |
| Tonix Medicines, INC. | $17.34 | 2024 | Zembrace Symtouch |
| Sumitomo Pharma America, INC. | $17.27 | 2023 | Aptiom |
| Alexion Pharmaceuticals, INC. | $16.86 | 2022 | |
| Idorsia Pharmaceuticals US INC | $16.63 | 2023 | Quviviq |
| Sk Life Science, INC. | $12.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audra Mcquade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.